This inventor holds 1 USPTO granted patent. Top assignee: Lg Chemical Ltd.. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Tae Sik Park: Innovator in CDK Inhibitors
Introduction
Tae Sik Park is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target critical biological pathways.
Latest Patents
One of his notable patents is focused on CDK inhibitors having a flavone structure. This invention relates to a novel flavone derivative, along with its pharmaceutically acceptable salt, hydrate, solvate, and isomer. The compound is useful as an inhibitor against Cyclin Dependent Kinase (CDK). The patent also details a process for the preparation of this compound and a composition of anti-cancer agents or agents for treating neurodegenerative diseases that include this compound as an active ingredient. Tae Sik Park holds 1 patent.
Career Highlights
Tae Sik Park is associated with LG Chemical Ltd., a leading company in the chemical and pharmaceutical industry. His work has contributed to advancements in drug development and therapeutic applications.
Collaborations
He has collaborated with notable colleagues, including Chang Yong Hong and Young Kwan Kim, to further enhance research and innovation in his field.
Conclusion
Tae Sik Park's innovative work in developing CDK inhibitors showcases his commitment to advancing medical science. His contributions are vital in the ongoing fight against cancer and neurodegenerative diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile